» Articles » PMID: 15486114

Autonomic Changes in Patients with Heart Failure and in Post-myocardial Infarction Patients

Overview
Journal Heart
Date 2004 Oct 16
PMID 15486114
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

A range of techniques for the assessment of autonomic tone are described. Impaired baroreflex control of heart period, measured in terms of heart rate variability or baroreflex sensitivity, is independently associated with adverse prognosis in patients with heart failure and following acute myocardial infarction. These techniques have not yet entered routine clinical practice.

Citing Articles

The impact of long COVID on heart rate variability: a cross-sectional study.

Qin M, Lee K, Yoo S BMC Infect Dis. 2025; 25(1):261.

PMID: 39994668 PMC: 11849358. DOI: 10.1186/s12879-024-10361-9.


Therapeutic Potential of Intermittent Hypoxia in Atrial Fibrillation.

Park H, Park B, Kim K, Son Y, Park S, Lee K Int J Mol Sci. 2024; 25(20).

PMID: 39456866 PMC: 11508233. DOI: 10.3390/ijms252011085.


Cardiovascular disease and psychiatric disorders: An-up-to date review.

Parlati A, Nardi E, Basile C, Paolillo S, Marzano F, Chirico A J Public Health Res. 2024; 13(4):22799036241278817.

PMID: 39398345 PMC: 11468319. DOI: 10.1177/22799036241278817.


The value of circadian heart rate variability for the estimation of obstructive sleep apnea severity in adult males.

Zhang B, Zhao M, Zhang X, Zhang X, Liu X, Huang W Sleep Breath. 2024; 28(3):1105-1118.

PMID: 38170376 DOI: 10.1007/s11325-023-02983-1.


Depression in Heart Failure with Reduced Ejection Fraction, an Undervalued Comorbidity: An Up-To-Date Review.

Basile C, Parlati A, Paolillo S, Marzano F, Nardi E, Chirico A Medicina (Kaunas). 2023; 59(5).

PMID: 37241180 PMC: 10224073. DOI: 10.3390/medicina59050948.


References
1.
Lumbers E, McCloskey D, Potter E . Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol. 1979; 294:69-80. PMC: 1280542. DOI: 10.1113/jphysiol.1979.sp012915. View

2.
Ferguson D, Berg W, Sanders J, Roach P, Kempf J, Kienzle M . Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation. 1989; 80(1):65-77. DOI: 10.1161/01.cir.80.1.65. View

3.
Nolan J, Batin P, Andrews R, Lindsay S, Brooksby P, Mullen M . Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998; 98(15):1510-6. DOI: 10.1161/01.cir.98.15.1510. View

4.
Bonaduce D, Marciano F, Petretta M, Migaux M, MORGANO G, Bianchi V . Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation. 1994; 90(1):108-13. DOI: 10.1161/01.cir.90.1.108. View

5.
Binkley P, Haas G, Starling R, Nunziata E, Hatton P, Leier C . Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 1993; 21(3):655-61. DOI: 10.1016/0735-1097(93)90098-l. View